Cargando…
Second cancer risk following Hodgkin lymphoma
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667959/ https://www.ncbi.nlm.nih.gov/pubmed/29108225 http://dx.doi.org/10.18632/oncotarget.20876 |
| _version_ | 1783275583140003840 |
|---|---|
| author | Sud, Amit Hemminki, Kari Houlston, Richard S. |
| author_facet | Sud, Amit Hemminki, Kari Houlston, Richard S. |
| author_sort | Sud, Amit |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5667959 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Impact Journals LLC |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-56679592017-11-04 Second cancer risk following Hodgkin lymphoma Sud, Amit Hemminki, Kari Houlston, Richard S. Oncotarget Editorial Impact Journals LLC 2017-09-14 /pmc/articles/PMC5667959/ /pubmed/29108225 http://dx.doi.org/10.18632/oncotarget.20876 Text en Copyright: © 2017 Sud et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Editorial Sud, Amit Hemminki, Kari Houlston, Richard S. Second cancer risk following Hodgkin lymphoma |
| title | Second cancer risk following Hodgkin lymphoma |
| title_full | Second cancer risk following Hodgkin lymphoma |
| title_fullStr | Second cancer risk following Hodgkin lymphoma |
| title_full_unstemmed | Second cancer risk following Hodgkin lymphoma |
| title_short | Second cancer risk following Hodgkin lymphoma |
| title_sort | second cancer risk following hodgkin lymphoma |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667959/ https://www.ncbi.nlm.nih.gov/pubmed/29108225 http://dx.doi.org/10.18632/oncotarget.20876 |
| work_keys_str_mv | AT sudamit secondcancerriskfollowinghodgkinlymphoma AT hemminkikari secondcancerriskfollowinghodgkinlymphoma AT houlstonrichards secondcancerriskfollowinghodgkinlymphoma |